Rchr
J-GLOBAL ID:200901071293165621   Update date: Apr. 26, 2024

Tashiro Shigeki

タシロ シゲキ | Tashiro Shigeki
Affiliation and department:
Job title: Data Manager
Research field  (3): Database science ,  Oral medicine (pathology) ,  Molecular biology
Research keywords  (3): Phospholipase A2 ,  data management ,  Clinical research
Research theme for competitive and other funds  (29):
  • 2022 - 2025 cPLA2
  • 2020 - 2024 口腔がんの進展・転移における低酸素環境下でのcPLA2の働き
  • 2020 - 2023 歯根吸収抑制におけるcPLA2の役割-硝子様変性と破歯細胞活性を標的にして-
  • 2019 - 2022 放射線によって活性化されるcPLA2の役割
  • 2013 - 2016 dual-function stress response protein
Show all
Papers (20):
  • Ko Chiba, Narihiro Okazaki, Ayako Kurogi, Tsuyoshi Watanabe, Ai Mori, Nobuhiko Suzuki, Koichi Adachi, Makoto Era, Kazuaki Yokota, Takuma Inoue, et al. Corrigendum to "Randomized controlled trial of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate in patients with postmenopausal osteoporosis: The TERABIT study" [Bone 160 (2022) 116416]. Bone. 2022. 162. 116484-116484
  • Ko Chiba, Narihiro Okazaki, Ayako Kurogi, Tsuyoshi Watanabe, Ai Mori, Nobuhiko Suzuki, Koichi Adachi, Makoto Era, Kazuaki Yokota, Takuma Inoue, et al. Randomized controlled trial of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate in patients with postmenopausal osteoporosis: The TERABIT study. Bone. 2022. 160. 116416-116416
  • Yuta Nakamura, Ichiro Horie, Shigeki Tashiro, Masaki Kobayashi, Tadahiro Kitamura, Yoshiki Kusunoki, Kenro Nishida, Akane Yamamoto, Yushi Hirota, Tomoyasu Fukui, et al. Study of glucagon response and its association with glycemic control and variability after administration of ipragliflozin as an adjunctive to insulin treatment in patients with type 1 diabetes (Suglat-AID). Medicine: Case Reports and Study Protocols. 2021. 2. 9. e0135-e0135
  • Ko Chiba, Shuta Yamada, Itaru Yoda, Makoto Era, Kazuaki Yokota, Narihiro Okazaki, Shingo Ota, Yusaku Isobe, Satsuki Miyazaki, Shigeki Tashiro, et al. Effects of monthly intravenous ibandronate on bone mineral density and microstructure in patients with primary osteoporosis after teriparatide treatment: The MONUMENT study. Bone. 2021. 144. 115770-115770
  • Atsuki Fukushima, Yuichi Hori, Takashi Itokawa, Shigeki Tashiro, Rina Kawasaki, Minoru Iwasaki, masayuki Nata. Evaluation of olopatadine ophthalmic solution by conjunctival allergen challenge test using Japanese cedar pollen antigen. 2021. 41. 13. 1188-1192
more...
MISC (4):
Lectures and oral presentations  (17):
  • cPLA2 conditional knockout mouse
    (2013)
  • cPLA2 コンディショナル・ノックアウトマウスの作成
    (日本歯科放射線学会 第31回関西・九州合同地方会(名古屋) 2011)
  • cPLA2と破骨細胞分化
    (第47回日本歯科放射線学会総会・学術大会(東京) 2006)
  • Heat shockストレスによってひき起こされたDNA障害におけるcPLA2の役割
    (第47回日本歯科放射線学会総会・学術大会(東京) 2006)
  • Heat-shock応答におけるcPLA2の役割
    (第28回日本分子生物学会年会(福岡) 2005)
more...
Education (3):
  • 1994 - 1997 Tokyo Institute of Technology Bioscience and Biotechnology
  • 1990 - 1993 The University of Tokyo
  • 1985 - 1990 Kyushu University School of Sciences Department of Biology
Professional career (2):
  • Ph.D (Tokyo Institute of Technology)
  • (BLANK) (The University of Tokyo)
Work history (7):
  • 2013/04 - 現在 Nagasaki University. Hospital Clinical Research Center
  • 2004/04 - 2013/03 Nagasaki University.
  • 1998/04 - 2004/03 Nagasaki University.
  • 1997 - 1998 理化学研究所 基礎科学 特別研究員
  • 1997 - 1998 Special Postdoctoral Researcher Laboratory of Molecular Genetics, Tsukuba Life Science Center, The Institute of Physical and Chemical Research (RIKEN)
Show all
Committee career (3):
  • - 2023/03 長崎大学病院 病歴委員会
  • 2014/04 - 2022/03 国立大学附属病院臨床研究推進会議 TG3
  • CDISC専門家連絡会
Association Membership(s) (2):
日本歯科放射線学会 ,  日本分子生物学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page